MinocherManeckBattiwallaMDMS
Hematology • Nashville, TNHematologic Oncology
Cellular Therapy and Allogeneic Stem Cell Transplantation
Dr. Battiwalla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2410 Patterson St
Ste 500
Nashville, TN 37203Phone+1 615-342-4912Fax+1 615-342-4913
Summary
- Dr. Minocher Battiwalla is a hematologist in Nashville, TN. He received his medical degree from Medical College and Hospital Kolkata and has been in practice 23 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1996 - 1999
Medical College and Hospital KolkataClass of 1994
Certifications & Licensure
TN State Medical License 2017 - 2025
AL State Medical License 2019 - 2022
MD State Medical License 2009 - 2018
NY State Medical License 2003 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants Start of enrollment: 2005 Apr 22
- Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants Start of enrollment: 2006 Sep 01
- Stem Cell Transplantation for Patients With Cancers of the Blood Start of enrollment: 2007 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsImpact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, Noam E Kopmar, Chenyu Lin
Blood Advances. 2024-12-10 - Access Barriers to Anti-CD19+ CART-Cell Therapy for NHL Across a Community Transplant and Cellular Therapy Network.Minoo Battiwalla, Michael T Tees, Ian W Flinn, Jeremy Pantin, Jesus G Berdeja
Blood Advances. 2024-10-17 - 1 citationsOutcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, Chenyu Lin, Simone E Dekker
Journal of Clinical Oncology. 2024-10-17
Abstracts/Posters
- Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the...Minoo Battiwalla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant: A Report from the Center for International Blood and Marrow Transplan...Minoo Battiwalla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...Minoo Battiwalla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
